Industry reports
Editor highlights

Search inside this page

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p7)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

181-230 of about 500 reports
World Drug and Medication: Tetanus - Pipeline Review, H1 2012

World Drug and Medication: Tetanus - Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • March 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Tetanus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Drug and Medication
  • Countries : Japan, World, United States, Australia
Synthon BV SWOT Analysis, Strategy, Revenues and Profits

Synthon BV SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug and Medication
  • Countries : Australia, United States
Ear Care Market Overview in Australia

Ear Care Market Overview in Australia

  • $ 898
  • Industry report
  • March 2013
  • by Euromonitor International

Sales in ear care increased by 4% in current value terms in 2009 to reach A$11 million in Australia. Similar to the preceding year, there was little product innovation in in ear care and manufacturers ...

  • Industries : Drug and Medication
  • Countries : Australia
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Australia

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in Australia

  • $ 898
  • Industry report
  • March 2013
  • by Euromonitor International

The end of the review period saw a particularly damp spring, for example, producing a particularly strong hay fever season, while cases of cold and flu also leapt considerably, particularly in Canberra ...

  • Industries : Drug and Medication
  • Countries : Australia
Digestive Remedies Market Analysis in Australia

Digestive Remedies Market Analysis in Australia

  • $ 898
  • Industry report
  • March 2013
  • by Euromonitor International

There are several reasons for such strong growth, but Australia’s ageing population has the greatest influence. As consumers grow older they become more prone to such conditions as constipation as well ...

  • Industries : Over-the-counter Drug
  • Countries : Australia
Vitamins and Dietary Supplements Market Analysis in Australia

Vitamins and Dietary Supplements Market Analysis in Australia

  • $ 898
  • Industry report
  • March 2013
  • by Euromonitor International

billion. Health and wellness trends in Australian society have encouraged consumers to take greater care of their health, and maintain optimal nutritional condition. Vitamins and dietary supplements also ...

  • Industries : Vitamin and Supplement
  • Countries : Australia
NRT Smoking Cessation Aids Market Analysis in Australia

NRT Smoking Cessation Aids Market Analysis in Australia

  • $ 898
  • Industry report
  • March 2013
  • by Euromonitor International

The first of these was the growing availability of these products through supermarkets. Until 2011 Nicabate was the only NRT smoking cessation aid product available in supermarkets, but 2011 saw Nicorette ...

  • Industries : Drug and Medication
  • Countries : Australia
Emergency Contraception Market Overview in Australia

Emergency Contraception Market Overview in Australia

  • $ 898
  • Industry report
  • March 2013
  • by Euromonitor International

In 2009, emergency contraception grew by 9% in current value terms to reach value sales of A$730,000 in Australia. Schering Pty Ltd reached out to educate member pharmacies in the Pharmacy Self Care’s ...

  • Industries : Drug and Medication
  • Countries : Australia
Analgesics Market Overview in Australia

Analgesics Market Overview in Australia

  • $ 898
  • Industry report
  • March 2013
  • by Euromonitor International

Following on the concerns about codeine-based analgesics misuse and consequent medical conditions including stomach ulcers and renal failure, the TGA decided on the upscheduling of combination products ...

  • Industries : Drug and Medication
  • Countries : Australia
MarketVIEW: Dengue vaccines

MarketVIEW: Dengue vaccines

  • $ 10 995
  • Industry report
  • March 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Dengue fever (DF) is a mosquito-borne disease (Aedes) which can affect two fifths of the world's population. DF infection has a wide spectrum of symptoms that range from a mild febrile illness to severe ...

  • Industries : Drug and Medication
  • Countries : Philippines, World, India, China, Asia, Australia, Indonesia, Bangladesh, Mexico, Vietnam, Thailand, Venezuela, Singapore
World Drug and Medication: Nausea - Pipeline Review, H1 2012

World Drug and Medication: Nausea - Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Nausea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Drug and Medication
  • Countries : World, Australia
OTC Medications - New Zealand (2012), Mintel

OTC Medications - New Zealand (2012), Mintel

  • $ 599
  • Industry report
  • February 2013
  • by Mintel

OTC Medications in New Zealand by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers analgesics, cough/cold/flu, gastro-intestinal, ...

  • Industries : Over-the-counter Drug
  • Countries : New Zealand
MarketVIEW: Hepatitis C virus vaccines

MarketVIEW: Hepatitis C virus vaccines

  • $ 9 995
  • Industry report
  • February 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Hepatitis C is caused by infection with the Hepatitis C virus (HCV). Transmission is predominately through the blood-to blood route where persons such as current or former injection drug users, past recipients ...

  • Industries : Drug and Medication
  • Countries : South Korea, Australia
Adacel Technologies Limited : Defense - Company Profile, SWOT and Financial Report

Adacel Technologies Limited : Defense - Company Profile, SWOT and Financial Report

  • $ 125
  • Company report
  • January 2013
  • by Strategic Defence Intelligence (SDI)

Synopsis Strategic Defence Intelligence's "Adacel Technologies Limited : Defense - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. ...

  • Industries : Drug and Medication
  • Countries : Australia
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

  • $ 3 500
  • Industry report
  • January 2013
  • by Global Data

Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Summary GlobalData's new report, ?Asia-Pacific Drug Delivery ...

  • Industries : Drug Delivery Technology
  • Countries : Australia, China, India, Japan
Australia Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Australia Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

  • $ 2 500
  • Industry report
  • January 2013
  • by Global Data

Australia Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Summary GlobalData's new report, ?Australia Drug Delivery ...

  • Industries : Drug Delivery Technology
  • Countries : Australia
The Pharmaceutical Market: Australia, Business Monitor International

The Pharmaceutical Market: Australia, Business Monitor International

  • $ 1 337
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN AUSTRALIA The country's health expenditure will continue to increase with the increasingly ...

  • Industries : Drug and Medication
  • Countries : Australia
The Pharmaceutical Market: New Zealand, Business Monitor International

The Pharmaceutical Market: New Zealand, Business Monitor International

  • $ 1 337
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN NEW ZEALAND Low growth potential in New Zealand's pharmaceutical market will attract ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Australian Pharmaceutical Industries Limited (Symbol:API) SWOT Analysis, Strategy, Revenues and Profits

Australian Pharmaceutical Industries Limited (Symbol:API) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • January 2013
  • by Global Data

Australian Pharmaceutical Industries Limited (API) is an in-store retailer. The company is engaged in the retailing, distribution and wholesaling of beauty and health products. In addition, it also undertakes ...

  • Industries : Pharmaceutical
  • Countries : Australia
MarketVIEW: Alzheimer%s disease vaccines

MarketVIEW: Alzheimer%s disease vaccines

  • $ 8 995
  • Industry report
  • January 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Alzheimer's Diseaseis the most common form of dementia first described by German neurologist Alois Alzhemier in 1906. It is an irreversible, progressive brain disease that destroys cognitive skills such ...

  • Industries : Pathology
  • Countries : Germany, Australia, United States, Canada, Spain, Italy, France, Japan, United Kingdom, World, Europe
Vitamins & Minerals - New Zealand  (2012)

Vitamins & Minerals - New Zealand (2012)

  • $ 599
  • Industry report
  • January 2013
  • by Mintel

Vitamins & Minerals in New Zealand by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers single/dual, multi-vitamins and ...

  • Industries : Vitamin and Supplement
  • Countries : New Zealand
PharmaPoint: Prostate Cancer - Australia Drug Forecast and Market Analysis to 2022

PharmaPoint: Prostate Cancer - Australia Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • December 2012
  • by Global Data

PharmaPoint: Prostate Cancer - Australia Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Prostate Cancer - Australia Drug Forecast and ...

  • Industries : Drug and Medication
  • Countries : Australia
Eligard (Prostate Cancer) - Forecast and Market Analysis to 2022

Eligard (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Eligard (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Eligard (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Australia, World, Canada, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, Oceania
Prostvac (Prostate Cancer) - Forecast and Market Analysis to 2022

Prostvac (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Prostvac (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Prostvac (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Trelstar (Prostate Cancer) - Forecast and Market Analysis to 2022

Trelstar (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Trelstar (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Trelstar (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Australia, World, Canada, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom, Oceania
Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022

Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Firmagon (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Firmagon (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022

Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Jevtana (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Jevtana (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022

Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Provenge (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Provenge (Prostate Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022

Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Zytiga (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Zytiga (Prostate Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : World, Australia, Canada, Spain, Italy, France, Germany, Japan, United States, Europe, United Kingdom
Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022

Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • December 2012
  • by Global Data

Xtandi (Prostate Cancer) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Xtandi (Prostate Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : World, Australia, United States, Canada, Spain, Italy, France, Germany, Japan, Europe, United Kingdom

» Read our Company Profiles

13 Companies

GlaxoSmithKline P.L.C.

United States

Management Strategies

United States

Abbott Laboratories

United States

Johnson and Johnson

United States

Medtronic Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.